# Gemcitabine

NDC: 25021-239
Generic name: gemcitabine
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190115

FDA application: ANDA209077

## Active ingredients

- GEMCITABINE HYDROCHLORIDE: 38 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-239"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-239
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22af3507-4b4f-4cad-9d61-89ffc4aabbc7